Physician profile
Regina Prindle
NPI 1104896075
$1,835.63
in general payments reported to CMS, 2019-2025
16 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $442 · 2023: $559 · 2024: $384 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.07 |
| Education | $144.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $461.95 | 2022-2025 | Uzedy, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $198.71 | 2021-2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $188.21 | 2021-2024 | Invega Sustenna, Invega Trinza |
| Sunovion Pharmaceuticals INC. | $172.11 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $150.50 | 2021-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Lundbeck LLC | $144.58 | 2021-2023 | Rexulti |
| Abbvie INC. | $106.53 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $104.73 | 2021-2024 | Ingrezza |
| Alkermes, INC. | $104.69 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Corium, LLC | $49.51 | 2022-2025 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $42.34 | 2024-2025 | Cobenfy |
| Indivior INC. | $40.04 | 2022 | |
| Sage Therapeutics, LLC | $26.66 | 2024 | |
| Ironshore Pharmaceuticals INC. | $18.61 | 2022 | |
| Eisai INC. | $13.67 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Prindle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.